Martin Lafontaine

Mr. Lafontaine has 21 years of experience within the pharmaceutical, medical device and digital health industry. He possesses strong expertise in commercial go-to-market product launch excellence, marketing, corporate development, and business development, in Canada, the US, and internationally.

Martin recently acts as an advisor to numerous development-stage pharmaceutical and medical device companies, in the field of diabetes. Prior to this, Martin held the role of Chief Commercial Officer for Locemia Solutions, a Montreal based company developing nasal glucagon for the rescue treatment of hypoglycemia, acquired by Eli Lilly in 2015.

His passion for diabetes has solid roots, beginning at age 13 when he was diagnosed with type 1 diabetes. He authored a chapter in the book, “Successful Men With Diabetes.”